nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—type 2 diabetes mellitus	0.155	0.387	CbGaD
Alosetron—CYP1A2—type 2 diabetes mellitus	0.148	0.369	CbGaD
Alosetron—CYP3A4—type 2 diabetes mellitus	0.0979	0.244	CbGaD
Alosetron—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0278	0.0693	CbGbCtD
Alosetron—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0254	0.0634	CbGbCtD
Alosetron—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0236	0.059	CbGbCtD
Alosetron—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0206	0.0513	CbGbCtD
Alosetron—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0201	0.0501	CbGbCtD
Alosetron—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0201	0.0501	CbGbCtD
Alosetron—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0185	0.0463	CbGbCtD
Alosetron—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0181	0.0452	CbGbCtD
Alosetron—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0179	0.0447	CbGbCtD
Alosetron—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0164	0.0409	CbGbCtD
Alosetron—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0162	0.0404	CbGbCtD
Alosetron—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0162	0.0403	CbGbCtD
Alosetron—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0153	0.0382	CbGbCtD
Alosetron—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0152	0.038	CbGbCtD
Alosetron—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0148	0.0369	CbGbCtD
Alosetron—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0146	0.0364	CbGbCtD
Alosetron—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0129	0.0322	CbGbCtD
Alosetron—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0117	0.0291	CbGbCtD
Alosetron—CYP1A2—Losartan—type 2 diabetes mellitus	0.0104	0.026	CbGbCtD
Alosetron—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0103	0.0257	CbGbCtD
Alosetron—CYP2C9—Losartan—type 2 diabetes mellitus	0.00941	0.0235	CbGbCtD
Alosetron—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00885	0.0221	CbGbCtD
Alosetron—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00849	0.0212	CbGbCtD
Alosetron—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00849	0.0212	CbGbCtD
Alosetron—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00803	0.02	CbGbCtD
Alosetron—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00598	0.0149	CbGbCtD
Alosetron—CYP3A4—Losartan—type 2 diabetes mellitus	0.00547	0.0136	CbGbCtD
Alosetron—Ondansetron—CYP2E1—type 2 diabetes mellitus	0.00107	0.387	CrCbGaD
Alosetron—Ondansetron—CYP1A2—type 2 diabetes mellitus	0.00102	0.369	CrCbGaD
Alosetron—Ondansetron—CYP3A4—type 2 diabetes mellitus	0.000673	0.244	CrCbGaD
Alosetron—Alopecia—Valsartan—type 2 diabetes mellitus	0.00013	0.000835	CcSEcCtD
Alosetron—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00013	0.000835	CcSEcCtD
Alosetron—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00013	0.000831	CcSEcCtD
Alosetron—Jaundice—Losartan—type 2 diabetes mellitus	0.000129	0.00083	CcSEcCtD
Alosetron—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000129	0.000828	CcSEcCtD
Alosetron—Alopecia—Orlistat—type 2 diabetes mellitus	0.000129	0.000825	CcSEcCtD
Alosetron—Confusional state—Glyburide—type 2 diabetes mellitus	0.000128	0.000821	CcSEcCtD
Alosetron—Sweating—Losartan—type 2 diabetes mellitus	0.000127	0.000816	CcSEcCtD
Alosetron—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000127	0.000813	CcSEcCtD
Alosetron—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000127	0.000813	CcSEcCtD
Alosetron—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000127	0.000812	CcSEcCtD
Alosetron—Flatulence—Valsartan—type 2 diabetes mellitus	0.000126	0.000811	CcSEcCtD
Alosetron—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000126	0.000811	CcSEcCtD
Alosetron—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000126	0.000808	CcSEcCtD
Alosetron—Malaise—Gliclazide—type 2 diabetes mellitus	0.000126	0.000808	CcSEcCtD
Alosetron—Rash—Repaglinide—type 2 diabetes mellitus	0.000126	0.000806	CcSEcCtD
Alosetron—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000126	0.000805	CcSEcCtD
Alosetron—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000126	0.000805	CcSEcCtD
Alosetron—Flatulence—Orlistat—type 2 diabetes mellitus	0.000125	0.000801	CcSEcCtD
Alosetron—Headache—Repaglinide—type 2 diabetes mellitus	0.000125	0.000801	CcSEcCtD
Alosetron—Sinusitis—Losartan—type 2 diabetes mellitus	0.000125	0.000799	CcSEcCtD
Alosetron—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000123	0.000791	CcSEcCtD
Alosetron—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000123	0.000787	CcSEcCtD
Alosetron—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000122	0.000785	CcSEcCtD
Alosetron—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000122	0.000784	CcSEcCtD
Alosetron—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000122	0.000782	CcSEcCtD
Alosetron—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000782	CcSEcCtD
Alosetron—Cough—Gliclazide—type 2 diabetes mellitus	0.000122	0.000782	CcSEcCtD
Alosetron—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000122	0.000779	CcSEcCtD
Alosetron—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000121	0.000773	CcSEcCtD
Alosetron—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000768	CcSEcCtD
Alosetron—Hepatitis—Losartan—type 2 diabetes mellitus	0.000119	0.000764	CcSEcCtD
Alosetron—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000119	0.000762	CcSEcCtD
Alosetron—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000119	0.000762	CcSEcCtD
Alosetron—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000761	CcSEcCtD
Alosetron—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000119	0.000761	CcSEcCtD
Alosetron—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000119	0.000761	CcSEcCtD
Alosetron—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000119	0.000761	CcSEcCtD
Alosetron—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000118	0.00076	CcSEcCtD
Alosetron—Nausea—Repaglinide—type 2 diabetes mellitus	0.000118	0.000759	CcSEcCtD
Alosetron—Asthenia—Glipizide—type 2 diabetes mellitus	0.000118	0.000759	CcSEcCtD
Alosetron—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000118	0.000757	CcSEcCtD
Alosetron—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000118	0.000754	CcSEcCtD
Alosetron—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000117	0.000753	CcSEcCtD
Alosetron—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000116	0.000747	CcSEcCtD
Alosetron—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000116	0.000746	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000116	0.000742	CcSEcCtD
Alosetron—Flatulence—Metformin—type 2 diabetes mellitus	0.000115	0.000738	CcSEcCtD
Alosetron—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000115	0.000737	CcSEcCtD
Alosetron—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000734	CcSEcCtD
Alosetron—Malaise—Orlistat—type 2 diabetes mellitus	0.000114	0.000733	CcSEcCtD
Alosetron—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000113	0.000727	CcSEcCtD
Alosetron—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000113	0.000727	CcSEcCtD
Alosetron—Infection—Gliclazide—type 2 diabetes mellitus	0.000113	0.000726	CcSEcCtD
Alosetron—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000726	CcSEcCtD
Alosetron—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000113	0.000725	CcSEcCtD
Alosetron—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000112	0.00072	CcSEcCtD
Alosetron—Cough—Valsartan—type 2 diabetes mellitus	0.000112	0.000718	CcSEcCtD
Alosetron—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000112	0.000718	CcSEcCtD
Alosetron—Jaundice—Ramipril—type 2 diabetes mellitus	0.000111	0.000712	CcSEcCtD
Alosetron—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000111	0.00071	CcSEcCtD
Alosetron—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000111	0.00071	CcSEcCtD
Alosetron—Cough—Orlistat—type 2 diabetes mellitus	0.000111	0.00071	CcSEcCtD
Alosetron—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00011	0.000708	CcSEcCtD
Alosetron—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000707	CcSEcCtD
Alosetron—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00011	0.000707	CcSEcCtD
Alosetron—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00011	0.000706	CcSEcCtD
Alosetron—Tremor—Metformin—type 2 diabetes mellitus	0.000109	0.000702	CcSEcCtD
Alosetron—Myalgia—Valsartan—type 2 diabetes mellitus	0.000109	0.000701	CcSEcCtD
Alosetron—Sweating—Ramipril—type 2 diabetes mellitus	0.000109	0.0007	CcSEcCtD
Alosetron—Anxiety—Valsartan—type 2 diabetes mellitus	0.000109	0.000698	CcSEcCtD
Alosetron—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000109	0.000697	CcSEcCtD
Alosetron—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000108	0.000695	CcSEcCtD
Alosetron—Myalgia—Orlistat—type 2 diabetes mellitus	0.000108	0.000692	CcSEcCtD
Alosetron—Anxiety—Orlistat—type 2 diabetes mellitus	0.000108	0.00069	CcSEcCtD
Alosetron—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000107	0.000685	CcSEcCtD
Alosetron—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000107	0.000685	CcSEcCtD
Alosetron—Discomfort—Orlistat—type 2 diabetes mellitus	0.000107	0.000684	CcSEcCtD
Alosetron—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000106	0.000683	CcSEcCtD
Alosetron—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000106	0.00068	CcSEcCtD
Alosetron—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000106	0.000677	CcSEcCtD
Alosetron—Malaise—Metformin—type 2 diabetes mellitus	0.000105	0.000676	CcSEcCtD
Alosetron—Alopecia—Losartan—type 2 diabetes mellitus	0.000105	0.000676	CcSEcCtD
Alosetron—Vomiting—Glipizide—type 2 diabetes mellitus	0.000105	0.000672	CcSEcCtD
Alosetron—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000105	0.000671	CcSEcCtD
Alosetron—Infection—Valsartan—type 2 diabetes mellitus	0.000104	0.000667	CcSEcCtD
Alosetron—Rash—Glipizide—type 2 diabetes mellitus	0.000104	0.000667	CcSEcCtD
Alosetron—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000104	0.000666	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000104	0.000666	CcSEcCtD
Alosetron—Headache—Glipizide—type 2 diabetes mellitus	0.000103	0.000663	CcSEcCtD
Alosetron—Tremor—Irbesartan—type 2 diabetes mellitus	0.000103	0.000663	CcSEcCtD
Alosetron—Infection—Orlistat—type 2 diabetes mellitus	0.000103	0.000659	CcSEcCtD
Alosetron—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000102	0.000656	CcSEcCtD
Alosetron—Flatulence—Losartan—type 2 diabetes mellitus	0.000102	0.000656	CcSEcCtD
Alosetron—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000102	0.000656	CcSEcCtD
Alosetron—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000102	0.000652	CcSEcCtD
Alosetron—Hypertension—Metformin—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Alosetron—Urticaria—Glyburide—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Alosetron—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000101	0.000645	CcSEcCtD
Alosetron—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.0001	0.000641	CcSEcCtD
Alosetron—Muscle spasms—Losartan—type 2 diabetes mellitus	9.98e-05	0.00064	CcSEcCtD
Alosetron—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.96e-05	0.000639	CcSEcCtD
Alosetron—Myalgia—Metformin—type 2 diabetes mellitus	9.95e-05	0.000638	CcSEcCtD
Alosetron—Malaise—Irbesartan—type 2 diabetes mellitus	9.94e-05	0.000638	CcSEcCtD
Alosetron—Headache—Pioglitazone—type 2 diabetes mellitus	9.9e-05	0.000635	CcSEcCtD
Alosetron—Discomfort—Metformin—type 2 diabetes mellitus	9.83e-05	0.00063	CcSEcCtD
Alosetron—Fatigue—Gliclazide—type 2 diabetes mellitus	9.83e-05	0.00063	CcSEcCtD
Alosetron—Nausea—Glipizide—type 2 diabetes mellitus	9.8e-05	0.000628	CcSEcCtD
Alosetron—Vomiting—Glimepiride—type 2 diabetes mellitus	9.79e-05	0.000628	CcSEcCtD
Alosetron—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.76e-05	0.000626	CcSEcCtD
Alosetron—Constipation—Gliclazide—type 2 diabetes mellitus	9.75e-05	0.000625	CcSEcCtD
Alosetron—Pain—Gliclazide—type 2 diabetes mellitus	9.75e-05	0.000625	CcSEcCtD
Alosetron—Tremor—Losartan—type 2 diabetes mellitus	9.72e-05	0.000623	CcSEcCtD
Alosetron—Rash—Glimepiride—type 2 diabetes mellitus	9.7e-05	0.000622	CcSEcCtD
Alosetron—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.7e-05	0.000622	CcSEcCtD
Alosetron—Rash—Sitagliptin—type 2 diabetes mellitus	9.67e-05	0.00062	CcSEcCtD
Alosetron—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.66e-05	0.00062	CcSEcCtD
Alosetron—Headache—Glimepiride—type 2 diabetes mellitus	9.64e-05	0.000618	CcSEcCtD
Alosetron—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.63e-05	0.000617	CcSEcCtD
Alosetron—Cough—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.000617	CcSEcCtD
Alosetron—Headache—Sitagliptin—type 2 diabetes mellitus	9.61e-05	0.000616	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.54e-05	0.000612	CcSEcCtD
Alosetron—Hypertension—Irbesartan—type 2 diabetes mellitus	9.52e-05	0.000611	CcSEcCtD
Alosetron—Infection—Metformin—type 2 diabetes mellitus	9.47e-05	0.000608	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.43e-05	0.000605	CcSEcCtD
Alosetron—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.39e-05	0.000602	CcSEcCtD
Alosetron—Myalgia—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000602	CcSEcCtD
Alosetron—Malaise—Losartan—type 2 diabetes mellitus	9.36e-05	0.0006	CcSEcCtD
Alosetron—Anxiety—Irbesartan—type 2 diabetes mellitus	9.36e-05	0.0006	CcSEcCtD
Alosetron—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.35e-05	0.0006	CcSEcCtD
Alosetron—Discomfort—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000595	CcSEcCtD
Alosetron—Skin disorder—Metformin—type 2 diabetes mellitus	9.26e-05	0.000594	CcSEcCtD
Alosetron—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.22e-05	0.000591	CcSEcCtD
Alosetron—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.000589	CcSEcCtD
Alosetron—Nausea—Glimepiride—type 2 diabetes mellitus	9.14e-05	0.000586	CcSEcCtD
Alosetron—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000586	CcSEcCtD
Alosetron—Nausea—Sitagliptin—type 2 diabetes mellitus	9.11e-05	0.000584	CcSEcCtD
Alosetron—Asthenia—Glyburide—type 2 diabetes mellitus	9.11e-05	0.000584	CcSEcCtD
Alosetron—Cough—Losartan—type 2 diabetes mellitus	9.06e-05	0.000581	CcSEcCtD
Alosetron—Urticaria—Gliclazide—type 2 diabetes mellitus	9.05e-05	0.000581	CcSEcCtD
Alosetron—Alopecia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000579	CcSEcCtD
Alosetron—Fatigue—Valsartan—type 2 diabetes mellitus	9.03e-05	0.000579	CcSEcCtD
Alosetron—Constipation—Valsartan—type 2 diabetes mellitus	8.95e-05	0.000574	CcSEcCtD
Alosetron—Infection—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000573	CcSEcCtD
Alosetron—Fatigue—Orlistat—type 2 diabetes mellitus	8.92e-05	0.000572	CcSEcCtD
Alosetron—Pain—Orlistat—type 2 diabetes mellitus	8.85e-05	0.000567	CcSEcCtD
Alosetron—Myalgia—Losartan—type 2 diabetes mellitus	8.83e-05	0.000567	CcSEcCtD
Alosetron—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.83e-05	0.000566	CcSEcCtD
Alosetron—Anxiety—Losartan—type 2 diabetes mellitus	8.8e-05	0.000565	CcSEcCtD
Alosetron—Rash—Bromocriptine—type 2 diabetes mellitus	8.75e-05	0.000561	CcSEcCtD
Alosetron—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.75e-05	0.000561	CcSEcCtD
Alosetron—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000561	CcSEcCtD
Alosetron—Discomfort—Losartan—type 2 diabetes mellitus	8.73e-05	0.00056	CcSEcCtD
Alosetron—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000558	CcSEcCtD
Alosetron—Headache—Bromocriptine—type 2 diabetes mellitus	8.7e-05	0.000558	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.69e-05	0.000557	CcSEcCtD
Alosetron—Dry mouth—Losartan—type 2 diabetes mellitus	8.64e-05	0.000554	CcSEcCtD
Alosetron—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000549	CcSEcCtD
Alosetron—Confusional state—Losartan—type 2 diabetes mellitus	8.54e-05	0.000548	CcSEcCtD
Alosetron—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.53e-05	0.000547	CcSEcCtD
Alosetron—Infection—Losartan—type 2 diabetes mellitus	8.41e-05	0.00054	CcSEcCtD
Alosetron—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.4e-05	0.000539	CcSEcCtD
Alosetron—Tremor—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000535	CcSEcCtD
Alosetron—Urticaria—Valsartan—type 2 diabetes mellitus	8.32e-05	0.000533	CcSEcCtD
Alosetron—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.26e-05	0.000529	CcSEcCtD
Alosetron—Nausea—Bromocriptine—type 2 diabetes mellitus	8.25e-05	0.000529	CcSEcCtD
Alosetron—Fatigue—Metformin—type 2 diabetes mellitus	8.22e-05	0.000527	CcSEcCtD
Alosetron—Urticaria—Orlistat—type 2 diabetes mellitus	8.22e-05	0.000527	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000526	CcSEcCtD
Alosetron—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.19e-05	0.000525	CcSEcCtD
Alosetron—Asthenia—Gliclazide—type 2 diabetes mellitus	8.18e-05	0.000524	CcSEcCtD
Alosetron—Constipation—Metformin—type 2 diabetes mellitus	8.15e-05	0.000523	CcSEcCtD
Alosetron—Vomiting—Glyburide—type 2 diabetes mellitus	8.07e-05	0.000518	CcSEcCtD
Alosetron—Malaise—Ramipril—type 2 diabetes mellitus	8.02e-05	0.000515	CcSEcCtD
Alosetron—Rash—Glyburide—type 2 diabetes mellitus	8e-05	0.000513	CcSEcCtD
Alosetron—Dermatitis—Glyburide—type 2 diabetes mellitus	8e-05	0.000513	CcSEcCtD
Alosetron—Headache—Glyburide—type 2 diabetes mellitus	7.95e-05	0.00051	CcSEcCtD
Alosetron—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.86e-05	0.000504	CcSEcCtD
Alosetron—Cough—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000498	CcSEcCtD
Alosetron—Fatigue—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000498	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.72e-05	0.000495	CcSEcCtD
Alosetron—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.72e-05	0.000495	CcSEcCtD
Alosetron—Pain—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000494	CcSEcCtD
Alosetron—Constipation—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000494	CcSEcCtD
Alosetron—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.62e-05	0.000489	CcSEcCtD
Alosetron—Urticaria—Metformin—type 2 diabetes mellitus	7.58e-05	0.000486	CcSEcCtD
Alosetron—Myalgia—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000486	CcSEcCtD
Alosetron—Anxiety—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000484	CcSEcCtD
Alosetron—Nausea—Glyburide—type 2 diabetes mellitus	7.54e-05	0.000484	CcSEcCtD
Alosetron—Asthenia—Valsartan—type 2 diabetes mellitus	7.51e-05	0.000482	CcSEcCtD
Alosetron—Discomfort—Ramipril—type 2 diabetes mellitus	7.48e-05	0.00048	CcSEcCtD
Alosetron—Asthenia—Orlistat—type 2 diabetes mellitus	7.42e-05	0.000476	CcSEcCtD
Alosetron—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000476	CcSEcCtD
Alosetron—Dry mouth—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000475	CcSEcCtD
Alosetron—Confusional state—Ramipril—type 2 diabetes mellitus	7.32e-05	0.00047	CcSEcCtD
Alosetron—Fatigue—Losartan—type 2 diabetes mellitus	7.3e-05	0.000468	CcSEcCtD
Alosetron—Vomiting—Gliclazide—type 2 diabetes mellitus	7.25e-05	0.000465	CcSEcCtD
Alosetron—Constipation—Losartan—type 2 diabetes mellitus	7.24e-05	0.000464	CcSEcCtD
Alosetron—Pain—Losartan—type 2 diabetes mellitus	7.24e-05	0.000464	CcSEcCtD
Alosetron—Rash—Gliclazide—type 2 diabetes mellitus	7.19e-05	0.000461	CcSEcCtD
Alosetron—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.18e-05	0.00046	CcSEcCtD
Alosetron—Urticaria—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000458	CcSEcCtD
Alosetron—Headache—Gliclazide—type 2 diabetes mellitus	7.14e-05	0.000458	CcSEcCtD
Alosetron—Skin disorder—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000452	CcSEcCtD
Alosetron—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.02e-05	0.00045	CcSEcCtD
Alosetron—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.98e-05	0.000448	CcSEcCtD
Alosetron—Asthenia—Metformin—type 2 diabetes mellitus	6.84e-05	0.000439	CcSEcCtD
Alosetron—Nausea—Gliclazide—type 2 diabetes mellitus	6.77e-05	0.000434	CcSEcCtD
Alosetron—Urticaria—Losartan—type 2 diabetes mellitus	6.73e-05	0.000431	CcSEcCtD
Alosetron—Vomiting—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000427	CcSEcCtD
Alosetron—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000425	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000424	CcSEcCtD
Alosetron—Rash—Valsartan—type 2 diabetes mellitus	6.6e-05	0.000423	CcSEcCtD
Alosetron—Dermatitis—Valsartan—type 2 diabetes mellitus	6.6e-05	0.000423	CcSEcCtD
Alosetron—Vomiting—Orlistat—type 2 diabetes mellitus	6.58e-05	0.000422	CcSEcCtD
Alosetron—Headache—Valsartan—type 2 diabetes mellitus	6.56e-05	0.000421	CcSEcCtD
Alosetron—Rash—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000418	CcSEcCtD
Alosetron—Dermatitis—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000418	CcSEcCtD
Alosetron—Headache—Orlistat—type 2 diabetes mellitus	6.48e-05	0.000416	CcSEcCtD
Alosetron—Asthenia—Irbesartan—type 2 diabetes mellitus	6.46e-05	0.000414	CcSEcCtD
Alosetron—Fatigue—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000402	CcSEcCtD
Alosetron—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.24e-05	0.0004	CcSEcCtD
Alosetron—Nausea—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000399	CcSEcCtD
Alosetron—Constipation—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000398	CcSEcCtD
Alosetron—Nausea—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000394	CcSEcCtD
Alosetron—Asthenia—Losartan—type 2 diabetes mellitus	6.08e-05	0.00039	CcSEcCtD
Alosetron—Vomiting—Metformin—type 2 diabetes mellitus	6.06e-05	0.000389	CcSEcCtD
Alosetron—Rash—Metformin—type 2 diabetes mellitus	6.01e-05	0.000386	CcSEcCtD
Alosetron—Dermatitis—Metformin—type 2 diabetes mellitus	6.01e-05	0.000385	CcSEcCtD
Alosetron—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000384	CcSEcCtD
Alosetron—Headache—Metformin—type 2 diabetes mellitus	5.97e-05	0.000383	CcSEcCtD
Alosetron—Urticaria—Ramipril—type 2 diabetes mellitus	5.77e-05	0.00037	CcSEcCtD
Alosetron—Vomiting—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000367	CcSEcCtD
Alosetron—Rash—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000364	CcSEcCtD
Alosetron—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000364	CcSEcCtD
Alosetron—Nausea—Metformin—type 2 diabetes mellitus	5.66e-05	0.000363	CcSEcCtD
Alosetron—Headache—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000362	CcSEcCtD
Alosetron—Vomiting—Losartan—type 2 diabetes mellitus	5.38e-05	0.000345	CcSEcCtD
Alosetron—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000343	CcSEcCtD
Alosetron—Nausea—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000343	CcSEcCtD
Alosetron—Rash—Losartan—type 2 diabetes mellitus	5.34e-05	0.000342	CcSEcCtD
Alosetron—Dermatitis—Losartan—type 2 diabetes mellitus	5.33e-05	0.000342	CcSEcCtD
Alosetron—Headache—Losartan—type 2 diabetes mellitus	5.31e-05	0.00034	CcSEcCtD
Alosetron—Asthenia—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000334	CcSEcCtD
Alosetron—Nausea—Losartan—type 2 diabetes mellitus	5.03e-05	0.000323	CcSEcCtD
Alosetron—Vomiting—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000296	CcSEcCtD
Alosetron—Rash—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000294	CcSEcCtD
Alosetron—Dermatitis—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000293	CcSEcCtD
Alosetron—Headache—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000292	CcSEcCtD
Alosetron—Nausea—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000277	CcSEcCtD
Alosetron—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	9.42e-06	0.000239	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	9.31e-06	0.000236	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.3e-06	0.000236	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	9.24e-06	0.000234	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	9.24e-06	0.000234	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.07e-06	0.00023	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.05e-06	0.000229	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.05e-06	0.000229	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	8.89e-06	0.000225	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	8.89e-06	0.000225	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	8.85e-06	0.000224	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.84e-06	0.000224	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	8.74e-06	0.000222	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	8.74e-06	0.000222	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.74e-06	0.000222	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	8.74e-06	0.000222	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	8.74e-06	0.000222	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	8.73e-06	0.000221	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	8.73e-06	0.000221	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	8.65e-06	0.000219	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	8.65e-06	0.000219	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	8.65e-06	0.000219	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	8.59e-06	0.000218	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	8.59e-06	0.000218	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	8.59e-06	0.000218	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	8.54e-06	0.000216	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	8.54e-06	0.000216	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	8.54e-06	0.000216	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	8.54e-06	0.000216	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	8.49e-06	0.000215	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.47e-06	0.000215	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	8.42e-06	0.000213	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.32e-06	0.000211	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.24e-06	0.000209	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.22e-06	0.000208	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	8.19e-06	0.000208	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	8.07e-06	0.000205	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8e-06	0.000203	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8e-06	0.000203	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.96e-06	0.000202	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.95e-06	0.000201	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.83e-06	0.000198	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.83e-06	0.000198	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.8e-06	0.000198	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.79e-06	0.000197	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.75e-06	0.000196	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.71e-06	0.000195	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.63e-06	0.000193	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	7.62e-06	0.000193	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	7.56e-06	0.000192	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.55e-06	0.000191	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	7.5e-06	0.00019	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.5e-06	0.00019	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.44e-06	0.000188	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.44e-06	0.000188	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.44e-06	0.000188	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.3e-06	0.000185	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.3e-06	0.000185	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.3e-06	0.000185	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.3e-06	0.000185	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.13e-06	0.000181	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.13e-06	0.000181	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.11e-06	0.00018	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.02e-06	0.000178	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	7e-06	0.000177	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.97e-06	0.000176	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.97e-06	0.000176	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.86e-06	0.000174	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.86e-06	0.000174	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.83e-06	0.000173	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.8e-06	0.000172	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.79e-06	0.000172	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.79e-06	0.000172	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.79e-06	0.000172	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.79e-06	0.000172	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.75e-06	0.000171	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.74e-06	0.000171	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.66e-06	0.000169	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.63e-06	0.000168	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.63e-06	0.000168	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.63e-06	0.000168	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.63e-06	0.000168	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.59e-06	0.000167	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.55e-06	0.000166	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.51e-06	0.000165	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	6.47e-06	0.000164	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.47e-06	0.000164	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	6.44e-06	0.000163	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	6.35e-06	0.000161	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.23e-06	0.000158	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	6.17e-06	0.000156	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.11e-06	0.000155	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.09e-06	0.000154	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.09e-06	0.000154	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.09e-06	0.000154	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.08e-06	0.000154	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	6e-06	0.000152	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.98e-06	0.000151	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.95e-06	0.000151	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.95e-06	0.000151	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.92e-06	0.00015	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	5.89e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.84e-06	0.000148	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.84e-06	0.000148	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.83e-06	0.000148	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.8e-06	0.000147	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.8e-06	0.000147	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.8e-06	0.000147	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.8e-06	0.000147	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.8e-06	0.000147	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.76e-06	0.000146	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	5.76e-06	0.000146	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	5.74e-06	0.000146	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.66e-06	0.000143	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.64e-06	0.000143	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.64e-06	0.000143	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.64e-06	0.000143	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.64e-06	0.000143	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.6e-06	0.000142	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	5.59e-06	0.000142	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.57e-06	0.000141	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.52e-06	0.00014	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.51e-06	0.000139	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.51e-06	0.000139	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.4e-06	0.000137	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.37e-06	0.000136	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.34e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	5.3e-06	0.000134	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.28e-06	0.000134	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.28e-06	0.000134	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.22e-06	0.000132	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.2e-06	0.000132	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.2e-06	0.000132	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.2e-06	0.000132	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	5.2e-06	0.000132	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.11e-06	0.000129	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.06e-06	0.000128	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	5.04e-06	0.000128	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.02e-06	0.000127	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.99e-06	0.000126	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	4.95e-06	0.000125	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.95e-06	0.000125	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	4.94e-06	0.000125	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	4.88e-06	0.000124	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.76e-06	0.000121	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.71e-06	0.000119	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.69e-06	0.000119	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.59e-06	0.000116	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.59e-06	0.000116	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.59e-06	0.000116	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.57e-06	0.000116	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.55e-06	0.000115	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.55e-06	0.000115	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.53e-06	0.000115	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.51e-06	0.000114	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.51e-06	0.000114	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.5e-06	0.000114	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.48e-06	0.000113	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.48e-06	0.000113	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.48e-06	0.000113	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.47e-06	0.000113	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.45e-06	0.000113	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.37e-06	0.000111	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.34e-06	0.00011	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.32e-06	0.000109	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	4.3e-06	0.000109	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.22e-06	0.000107	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	4.22e-06	0.000107	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.14e-06	0.000105	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.06e-06	0.000103	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.04e-06	0.000102	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.02e-06	0.000102	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.02e-06	0.000102	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.02e-06	0.000102	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.94e-06	9.98e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.94e-06	9.97e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.91e-06	9.9e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.89e-06	9.85e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.89e-06	9.85e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.89e-06	9.85e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.87e-06	9.8e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	3.87e-06	9.79e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.82e-06	9.68e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.82e-06	9.67e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.73e-06	9.45e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.71e-06	9.39e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	3.7e-06	9.37e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.7e-06	9.37e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.67e-06	9.3e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.66e-06	9.27e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.63e-06	9.2e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.63e-06	9.2e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.61e-06	9.14e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.54e-06	8.98e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.54e-06	8.97e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.48e-06	8.83e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.48e-06	8.82e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.48e-06	8.82e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.47e-06	8.8e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.47e-06	8.78e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.45e-06	8.75e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.43e-06	8.7e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	3.38e-06	8.57e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.36e-06	8.52e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.32e-06	8.41e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.19e-06	8.07e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.13e-06	7.92e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.03e-06	7.67e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.02e-06	7.66e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3e-06	7.6e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3e-06	7.6e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.99e-06	7.57e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.98e-06	7.54e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.97e-06	7.52e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.97e-06	7.51e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.95e-06	7.47e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.93e-06	7.43e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.86e-06	7.25e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.78e-06	7.05e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.73e-06	6.92e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.72e-06	6.89e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.67e-06	6.78e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.67e-06	6.75e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.6e-06	6.59e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.6e-06	6.59e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.6e-06	6.58e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.58e-06	6.55e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.56e-06	6.49e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.53e-06	6.42e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.46e-06	6.23e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.41e-06	6.11e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.38e-06	6.03e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.34e-06	5.92e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.32e-06	5.89e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.3e-06	5.82e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.29e-06	5.8e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.26e-06	5.73e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.22e-06	5.63e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.22e-06	5.63e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.03e-06	5.15e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.99e-06	5.05e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.96e-06	4.96e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.79e-06	4.54e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-06	4.35e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-06	4.35e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.7e-06	4.31e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.57e-06	3.98e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.2e-06	3.03e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	2.59e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.89e-07	2e-05	CbGpPWpGaD
